A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples